The EU Commission opens investigation against two pharmaceutical companies on account of patent settlement agreement (Cephalon / Teva)

On 28 April 2011, the European Commission opened of its own motion formal competition proceedings against Cephalon, Inc. (“Cephalon”) and Teva

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Van Bael & Bellis (Brussels)

Quotation

Peter L'Ecluse, The EU Commission opens investigation against two pharmaceutical companies on account of patent settlement agreement (Cephalon / Teva), 28 April 2011, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 41138

Visites 319

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues